Mark Leick

36PUBLICATIONS
128CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 02, 2026
Rational Engineering of Notch1 Signaling to Boost the Proliferation of CD19-BBζ CAR-T.

|Jul 24, 2026
Genomic correlates of clinical CAR T cell activity.

|Feb 13, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma.

Eli P Darnell, Kathleen M E Gallagher, Justyna Kanska

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Dec 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer.

Sangwoo Park, Cassidy E Ho, Eli P Darnell

|Nov 13, 2025
Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer.

Alexander Armstrong, Graziella van der Plancke, Sae Nishiguchi

Pageof 6

Frequent Collaborators

28 joint publications

Marcela V Maus

11 joint publications

Filippo Birocchi

10 joint publications

Giulia Escobar

8 joint publications

Alexander Armstrong